PillSorted raises £4.8m in seed funding from Pear VC and other backers to develop its technology and expand its team.
The seed round was backed by Pear VC, Hoxton Ventures, Edison Partners, and the founders of DoorDash.
PillSorted operates a personalised digital pharmacy service that combines automated dispensing systems with dedicated delivery fleets. The firm aims to improve health outcomes and streamline operations across the healthcare sector.
PillSorted has secured £4.8m in seed funding to advance its digital pharmacy technology and grow its workforce. The investment was backed by Pear VC, Hoxton Ventures, Edison Partners, and the founders of DoorDash. The capital will enable the firm to refine its predictive medication tools and scale operations throughout the UK.
Founded in 2019, the healthtech startup combines smart automation with personalised patient care to reduce administrative burdens on pharmacists. The fresh capital supports the company as it develops its product offerings and expands its presence in the domestic market.
From the founder
"The typical pharmacy experience has long been in need of an upgrade, and most pharmacists, despite being well trained and highly knowledgeable, are so bogged down by manual, repetitive tasks that they only have time to provide a basic, transactional service. Our mission is to provide a personalised pharmacy service for people who are on lots of medication that makes accessing the drugs and support they need a whole lot easier for them."
Zeinab Ardeshir
CEO and Co-founder at PillSorted
Investor perspective
"We’re excited to team up with Pear VC and support PillSorted in its mission to build a scalable community pharmacy that can deliver efficient and personalised care for patients and customers."
Hussein Kanji
Partner, Hoxton Ventures
Use of funds
- 01Continue product development
- 02Grow the team
- 03Expand into international markets
Investors
Categories
About the company
PillSorted
PillSorted provides a digital pharmacy service and automated dispensary system for patients.